Stifimol (garcinia extract, L-tyrosin, L-carnitine) hard capsules №100

Description

Stifimol (garcinia extract, L-tyrosin, L-carnitine) hard capsules №100

Composition

substances: 1 capsule contains garcinia cambogia extract (Garcinia cambogia) 100 mg, corresponding to hydroxycitric acid 50 mg, chromium picolinate 0.1 mg, L-tyrosine (tyrosine) 50 mg, levocarnitine (L-carnitine) 15 mg, brown algae dry extract (Fucus vesiculosus L.), in terms of iodine 0.037 mg;

excipients: microcrystalline cellulose; magnesium carbonate light; lactose monohydrate; talc; calcium stearate; corn starch;

hard gelatin capsule contains: gelatin, indigotine (E 132), quinoline yellow (E 104), titanium dioxide (E 171).

Dosage form

Hard capsules.

Main physical and chemical properties: hard gelatin capsules with a light green lid and a dark green body. The content of the capsules is a light brown granular powder.

Pharmacotherapeutic group

Remedies for obesity, except for dietary products.
ATX code A08A.

Pharmacological properties

A remedy used for obesity. Its main component – garcinia cambogia extract – inhibits the process of lipogenesis (the formation of fats in the body), reduces appetite, increases the production of heat by the body due to the activation of the process of thermogenesis.

Indications

The pharmaceutical preparation Stifimol is used in case of increased body weight or a tendency to obesity. Also, this drug can be used to reduce hunger during a diet.

Contraindications

It is forbidden to use Stifimol in case of hypersensitivity to its ingredients, including iodine.
You can not use this pharmaceutical product in children (insufficient clinical data).
With caution, Stifimol can be used in patients with cardiovascular pathologies, thyroid diseases, and diseases of the digestive tract. In case of pathologies of the thyroid gland, the presence of iodine in this pharmaceutical preparation should be taken into account (37 μg in one capsule of Stifimol). In such cases, Stifimol therapy is allowed only after consultation with your doctor.

Application during pregnancy and lactation

You can not apply the pharmaceutical drug Stifimol to women during these periods (there is not enough clinical data).

Method of administration and dosage

Patients are given one capsule of Stifimol two or three times a day. The drug should be taken before meals and the capsule should be taken with a glass of water.
The duration of the course of therapy with this pharmaceutical agent is four to six weeks. Repeated courses are allowed only after a two-three month break.
During the course of using the pharmaceutical preparation Stifimol, it is recommended to simultaneously receive a multivitamin complex. The latter is required to be taken no earlier than two hours after taking the Stifimol capsule.

Overdose

In case of an overdose of the drug Stifimol, dysfunction of the thyroid gland, digestive tract (diarrhea), cardiovascular system (tachycardia, increased blood pressure) are possible.
If there are signs of an overdose, it is necessary to stop using this pharmaceutical product, to provide the patient with symptomatic treatment.

Side effects

When using Stifimol in recommended doses, the drug is usually well tolerated and rarely contributes to the development of undesirable effects. Side effects, as a rule, are associated with individual intolerance to one of the components of this pharmaceutical product.
There may be undesirable effects on the part of the cardiovascular system (tachycardia, increased blood pressure), thyroid function, digestive tract (diarrhea).
In the event of any undesirable phenomenon occurring against the background of the use of the drug Stifimol, you must stop using it and contact your doctor for advice.